Capvizr
News · All summaries
Healthcare & Life Sciences
Alchemab Therapeutics
Series A$32 million
RoundSeries A
Amount$32 million
LeadBritish Business Bank
HQLondon, United Kingdom
DateJuly 8, 2026
THE DEAL, AT A GLANCE

Alchemab Therapeutics

From the announcement
Who is involvedBacked by British Business BankFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedAlchemab Therapeutics raised $32M Series A, announced 2026-07-08From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersAlchemab Therapeutics’ $32M Series A extension positions the company as a below-median Healthcare & Life Sciences financing in a sector with broad recent funding…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Alchemab Therapeutics · Financing Record

Explore source-linked visual explanations for Alchemab Therapeutics. Unsupported claims are withheld while source review continues.

Record 7780 · Recorded date: 2026-07-08

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime